Insider · CIK 0001033369

RUBINFELD JOSEPH

Reports to the SEC for 3 companies · LOS ANGELES, CA

sec.gov

Transactions

Companies

Filings

CIK

0001033369

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-12-15	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+180K sh	—	—	180,000
2015-12-15	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+180K sh	—	—	180,000
2015-01-12	Amarantus Bioscience Holdings, Inc.Option to Purchase Common StockA Award	Director	AAward	+6.69M sh	—	—	6,690,000
2014-12-15	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+180K sh	—	—	180,000
2014-12-15	LADXLadRx Corp · Stock option (right to buy)A Award	Director	AAward	+180K sh	—	—	180,000
2014-12-08	Amarantus Bioscience Holdings, Inc.A Award	Director	AAward	+117K sh	$0.09	+$9,914.15	2,056,500
2013-12-10	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+180K sh	—	—	180,000
2012-12-10	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2012-12-10	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2012-05-14	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2011-06-30	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2010-06-29	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2009-07-01	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+350K sh	—	—	350,000
2009-07-01	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2007-07-10	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2005-07-18	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2004-07-30	LADXLadRx Corp · Stock Option (right to buy)A Award	Director	AAward	+10K sh	$1.20	+$12K	10,000
2004-01-08	Astex Pharmaceuticals, IncEmployee Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,399 sh	—	—	98,601
2004-01-08	Astex Pharmaceuticals, IncEmployee Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,334 sh	—	—	0
2004-01-08	Astex Pharmaceuticals, IncF Tax Payment	Director	FTax Payment	−4,125 sh	$11.86	−$48.9K	1,410,254
2004-01-08	Astex Pharmaceuticals, IncF Tax Payment	Director	FTax Payment	−509 sh	$11.86	−$6,036.74	1,409,745
2004-01-08	Astex Pharmaceuticals, IncF Tax Payment	Director	FTax Payment	−574 sh	$11.86	−$6,807.64	1,409,171
2004-01-08	Astex Pharmaceuticals, IncF Tax Payment	Director	FTax Payment	−770 sh	$11.86	−$9,132.2	1,408,401
2004-01-08	Astex Pharmaceuticals, IncF Tax Payment	Director	FTax Payment	−590 sh	$11.86	−$6,997.4	1,407,811
2004-01-08	Astex Pharmaceuticals, IncF Tax Payment	Director	FTax Payment	−693 sh	$11.86	−$8,218.98	1,407,118
2004-01-08	Astex Pharmaceuticals, IncM Exercise/Conversion	Director	MExercise/Conversion	+16.2K sh	$3.02	+$48.9K	1,423,318
2004-01-08	Astex Pharmaceuticals, IncM Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	$4.03	+$6,045	1,424,818
2004-01-08	Astex Pharmaceuticals, IncM Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	$4.54	+$6,810	1,426,318
2004-01-08	Astex Pharmaceuticals, IncM Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	$4.57	+$9,140	1,428,318
2004-01-08	Astex Pharmaceuticals, IncM Exercise/Conversion	Director	MExercise/Conversion	+1,334 sh	$5.25	+$7,003.5	1,429,652
2004-01-08	Astex Pharmaceuticals, IncM Exercise/Conversion	Director	MExercise/Conversion	+1,399 sh	$5.88	+$8,226.12	1,431,051
2004-01-08	Astex Pharmaceuticals, IncEmployee Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−16.2K sh	—	—	0
2004-01-08	Astex Pharmaceuticals, IncEmployee Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	—	—	0
2004-01-08	Astex Pharmaceuticals, IncEmployee Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	—	—	0
2004-01-08	Astex Pharmaceuticals, IncEmployee Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	0
2003-12-31	Astex Pharmaceuticals, IncF Tax Payment	Director	FTax Payment	−826 sh	$11.00	−$9,086	1,402,786
2003-12-31	Astex Pharmaceuticals, IncF Tax Payment	Director	FTax Payment	−1,477 sh	$11.00	−$16.2K	1,391,873
2003-12-31	Astex Pharmaceuticals, IncF Tax Payment	Director	FTax Payment	−267 sh	$11.00	−$2,937	1,393,350
2003-12-31	Astex Pharmaceuticals, IncF Tax Payment	Director	FTax Payment	−79 sh	$11.00	−$869	1,393,617
2003-12-31	Astex Pharmaceuticals, IncF Tax Payment	Director	FTax Payment	−9,090 sh	$11.00	−$100K	1,393,696
2003-12-31	Astex Pharmaceuticals, IncEmployee Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	0
2003-12-31	Astex Pharmaceuticals, IncEmployee Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−500 sh	—	—	0
2003-12-31	Astex Pharmaceuticals, IncEmployee Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−166 sh	—	—	1,334
2003-12-31	Astex Pharmaceuticals, IncEmployee Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−16.7K sh	—	—	483,334
2003-12-31	Astex Pharmaceuticals, IncEmployee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,674 sh	—	—	15,589
2003-12-31	Astex Pharmaceuticals, IncM Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$6.50	+$16.3K	1,414,379
2003-12-31	Astex Pharmaceuticals, IncM Exercise/Conversion	Director	MExercise/Conversion	+500 sh	$5.88	+$2,940	1,411,879
2003-12-31	Astex Pharmaceuticals, IncM Exercise/Conversion	Director	MExercise/Conversion	+166 sh	$5.25	+$871.5	1,411,379
2003-12-31	Astex Pharmaceuticals, IncM Exercise/Conversion	Director	MExercise/Conversion	+16.7K sh	$6.00	+$100K	1,411,213
2003-12-31	Astex Pharmaceuticals, IncM Exercise/Conversion	Director	MExercise/Conversion	+2,674 sh	$3.40	+$9,091.6	1,394,547

Recent filings

Accepted (ET)
Dec 194
CYTRX CORP0001140361-16-090180
SEC(opens sec.gov)
Dec 174
CYTRX CORP0001140361-15-044872
SEC(opens sec.gov)
Jan 154
Amarantus Bioscience Holdings, Inc.0001144204-15-002318
SEC(opens sec.gov)
Dec 164
CYTRX CORP0001140361-14-045489
SEC(opens sec.gov)
Dec 164/A
CYTRX CORP0001140361-14-045509
SEC(opens sec.gov)
Dec 84
Amarantus Bioscience Holdings, Inc.0001144204-14-072723
SEC(opens sec.gov)
Dec 124
CYTRX CORP0001250853-13-000141
SEC(opens sec.gov)
Dec 114
RUBINFELD JOSEPH0001250853-12-000103
SEC(opens sec.gov)
May 154
RUBINFELD JOSEPH0001250853-12-000042
SEC(opens sec.gov)
Jul 14
RUBINFELD JOSEPH0001250853-11-000049
SEC(opens sec.gov)
Jul 14
RUBINFELD JOSEPH0001250853-10-000041
SEC(opens sec.gov)
Jul 64
RUBINFELD JOSEPH0001250853-09-000057
SEC(opens sec.gov)
Jul 124
CYTRX CORP0001250853-07-000100
SEC(opens sec.gov)
Jul 194
CYTRX CORP0001250853-05-000094
SEC(opens sec.gov)
Aug 134
CYTRX CORP0001250853-04-000065
SEC(opens sec.gov)
Jan 124
SUPERGEN INC0001179110-04-001021
SEC(opens sec.gov)

Companies

Address

11726 SAN VICENTE BLVD, #650

LOS ANGELES, CA, 90049